Literature DB >> 314359

The risk of optic atrophy following suramin treatment of ocular onchocerciasis.

B Thylefors, A Rolland.   

Abstract

Treatment of onchocerciasis with suramin in an area of vector control led to an increased incidence of optic atrophy in treated patients compared to an untreated group.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 314359      PMCID: PMC2395819     

Source DB:  PubMed          Journal:  Bull World Health Organ        ISSN: 0042-9686            Impact factor:   9.408


  7 in total

1.  The pathogenesis and pathology of ocular on-chocerciasis. Part IV. The pathology.

Authors:  F C RODGER
Journal:  Am J Ophthalmol       Date:  1960-03       Impact factor: 5.258

2.  [An onchocerciasic papillitis].

Authors:  J Vedy; J Sirol
Journal:  Med Trop (Mars)       Date:  1971 Sep-Oct

3.  Further studies on the treatment of ocular onchocerciasis with diethylcarbamazine and suramin.

Authors:  J Anderson; H Fuglsang
Journal:  Br J Ophthalmol       Date:  1978-07       Impact factor: 4.638

4.  [Degeneration of choroid vessels in onchocerciasis].

Authors:  H J Trojan
Journal:  Rev Int Trach Pathol Ocul Trop Subtrop       Date:  1977

5.  The effects of drugs on Onchocerca volvulus. 3. Trials of suramin at different dosages and a comparison of the brands Antrypol, Moranyl and Naganol.

Authors:  B O Duke
Journal:  Bull World Health Organ       Date:  1968       Impact factor: 9.408

6.  Effects of suramin on ocular onchocerciasis.

Authors:  J Anderson; H Fuglsang; T F de C Marshall
Journal:  Tropenmed Parasitol       Date:  1976-09

7.  The natural history of ocular onchocerciasis over a period of 14--15 years and the effect on this of a single course of suramin therapy.

Authors:  F H Budden
Journal:  Trans R Soc Trop Med Hyg       Date:  1976       Impact factor: 2.184

  7 in total
  7 in total

1.  [Treatment of onchocerciasis with low, increasing doses of suramin in hyperendemic communities of Western Africa: 2. Clinical parasitologic and ophthalmologic results in a zone where transmission is controlled].

Authors:  A Rougemont; M Hien; B Thylefors; A Prost; A Rolland
Journal:  Bull World Health Organ       Date:  1984       Impact factor: 9.408

2.  [Treatment of onchocerciasis in hyperendemic communities in West Africa with small, gradually increasing doses of suramin. 1. Parasitological results and ophthalmological surveillance in a region where transmission has not been interrupted].

Authors:  A Rougemont; B Thylefors; M Ducam; A Prost; P Ranque; J Delmont
Journal:  Bull World Health Organ       Date:  1980       Impact factor: 9.408

3.  Ocular findings in a double-blind study of ivermectin versus diethylcarbamazine versus placebo in the treatment of onchocerciasis.

Authors:  K Y Dadzie; A C Bird; K Awadzi; H Schulz-Key; H M Gilles; M A Aziz
Journal:  Br J Ophthalmol       Date:  1987-02       Impact factor: 4.638

4.  Ocular changes with oral and transepidermal diethylcarbamazine therapy of onchocerciasis.

Authors:  H R Taylor; B M Greene
Journal:  Br J Ophthalmol       Date:  1981-07       Impact factor: 4.638

5.  Ocular onchocerciasis: current management and future prospects.

Authors:  Olufemi Emmanuel Babalola
Journal:  Clin Ophthalmol       Date:  2011-10-13

6.  Clinical picture and outcome of Serious Adverse Events in the treatment of Onchocerciasis.

Authors:  Kwablah Awadzi
Journal:  Filaria J       Date:  2003-10-24

7.  Macrofilaricides and onchocerciasis control, mathematical modelling of the prospects for elimination.

Authors:  W S Alley; G J van Oortmarssen; B A Boatin; N J Nagelkerke; A P Plaisier; J H Remme; J Lazdins; G J Borsboom; J D Habbema
Journal:  BMC Public Health       Date:  2001-11-06       Impact factor: 3.295

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.